Mol Hans G J, Elbers Ingrid, Pälmke Claudia, Bury Daniel, Göen Thomas, López Marta Esteban, Nübler Stefanie, Vaccher Vincent, Antignac Jean-Philippe, Dvořáková Darina, Hajšlová Jana, Sakhi Amrit Kaur, Thomsen Cathrine, Vorkamp Katrin, Castaño Argelia, Koch Holger M
Wageningen Food Safety Research, Part of Wageningen University & Research, 6708 WB Wageningen, The Netherlands.
Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum, 44789 Bochum, Germany.
Toxics. 2022 Jan 26;10(2):57. doi: 10.3390/toxics10020057.
A quality assurance/quality control program was implemented in the framework of the EU project HBM4EU to assess and improve the comparability of biomarker analysis and to build a network of competent laboratories. Four rounds of proficiency tests were organized for 15 phthalate and two DINCH urinary biomarkers (0.2-138 ng/mL) over a period of 18 months, with the involvement of 28 laboratories. A substantial improvement in performance was observed after the first round in particular, and by the end of the program, an average satisfactory performance rate of 90% was achieved. The interlaboratory reproducibility as derived from the participants' results varied for the various biomarkers and rounds, with an average of 24% for the biomarkers of eight single-isomer phthalates (e.g., DnBP and DEHP) and 43% for the more challenging biomarkers of the mixed-isomer phthalates (DiNP, DiDP) and DINCH. When the reproducibility was based only on the laboratories that consistently achieved a satisfactory performance, this improved to 17% and 26%, respectively, clearly demonstrating the success of the QA/QC efforts. The program thus aided in building capacity and the establishment of a network of competent laboratories able to generate comparable and accurate HBM data for phthalate and DINCH biomarkers in 14 EU countries. In addition, global comparability was ensured by including external expert laboratories.
在欧盟项目HBM4EU的框架内实施了一项质量保证/质量控制计划,以评估和提高生物标志物分析的可比性,并建立一个合格实验室网络。在18个月的时间里,针对15种邻苯二甲酸盐和两种DINCH尿液生物标志物(0.2 - 138 ng/mL)组织了四轮能力验证测试,有28个实验室参与。特别是在第一轮之后,观察到性能有了显著提高,到项目结束时,平均满意性能率达到了90%。根据参与者的结果得出的实验室间再现性因各种生物标志物和轮次而异,八种单异构体邻苯二甲酸盐(如DnBP和DEHP)的生物标志物平均为24%,混合异构体邻苯二甲酸盐(DiNP、DiDP)和DINCH的更具挑战性的生物标志物平均为43%。当再现性仅基于始终取得满意性能的实验室时,这一比例分别提高到了17%和26%,清楚地证明了质量保证/质量控制工作的成功。该计划因此有助于建设能力,并建立一个合格实验室网络,能够为14个欧盟国家的邻苯二甲酸盐和DINCH生物标志物生成可比且准确的人类生物监测数据。此外,通过纳入外部专家实验室确保了全球可比性。